期刊文献+

奥沙利铂神经毒性处理及预防研究进展 被引量:12

The Progress in Treatment and Prevention of OXA about its Neurotoxicity
下载PDF
导出
摘要 神经毒性是OXA最常发生的剂量限制性毒性,近期研究发现OXA急性毒性的产生可能与一过性的钙依赖的钠通道功能失调有关,这一作用可被Na+通道阻滞剂所阻断,临床发现支持这一观点,这些临床发现指出药学性阻断Na+通道可预防和(或)抑制OXA的神经毒性。本文综述了OXA神经毒性的细胞机制、病理生理及处理预防措施进展。 Neurotoxicity is the most frequent dose-limiting toxicity-of oxaliplatin, Recent data indicates that the acute toxicity of oxaliplatin maybe associated with temple functional disorder of sodium channel depended on calcium, which can be inhibited by sodium channel blocker. Many clinical found can also support this view, which indicates phamnceuticcal inhibition of sodium channel can prevent/inhibite the neurotexicity of oxaliplatin. This article reviews the progress of OXA about its cell mechanism,pathophysiology and methods of treatment and prevention.
出处 《医学综述》 2006年第8期490-492,共3页 Medical Recapitulate
关键词 奥沙利铂 神经毒性 预防 神经调节剂 Oxaliplatin Ncurotoxicity Prevention Neuroregulator
  • 相关文献

参考文献19

  • 1Grothey A, Schmoll HJ. New chemotherapy approaches in colorectal cancer[J]. Curt Opin Oncol,2001,13(4) :275-286.
  • 2Beeouam Y, Agostini C, Trufflandier N, et al. Oradiplatin : Available data in non-colorectal gastrointestinal malignancies[J]. Crit Rev Oncol Hematol, 2001,40(3):265-272.
  • 3Cassidy J, Misaet JL. Oxalipatin-related side effects: Characteris ticsand management[J]. Semin 0neol,2002,29[5 Suppl 15] : 11-20.
  • 4Wilson RH,Lehky T,Thomas RR, et al. Acute oxaliplatin-induced peripheral nerve hyperexcitability[J].J Clin Oncol, 2002,20 (7):1767-1774.
  • 5姚智东,吴洪斌.奥沙利铂的安全性评价[J].中国新药杂志,2003,12(7):567-569. 被引量:79
  • 6Adelsherger H, Quasthoff S, Groeskreutz J, at al. The chemotherapeutic oxaliplatin alters voltage-gated Na^+ channel kinetics on rat sensory neurons[J] .Eur J Pharmacol,2000,406(1) :25-32.
  • 7Maindrault- Gocbel F, Toumigand C, Andre T, et al. Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer[J]. Ann Oncol, 2004, 15(8) : 1210-1214.
  • 8Cersosimo RJ. Oxaliplatin-associated neuropathy: a review [J]. Ann Pharmaeother, 2005,39( 1 ) : 128-135.
  • 9Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy[J] .J Neurol,2002,249(1) :9-17.
  • 10郑宇,潘宏铭,楼海舟,楼芳,张在云.硫酸镁预防奥沙利铂神经毒性的临床观察[J].实用肿瘤杂志,2004,19(2):154-155. 被引量:52

二级参考文献18

  • 1胡发明.奥沙利铂的不良反应和安全性[J].国外医药合成药·生化药·制剂分册,1999,20(3):184-185.
  • 2Richard H, Wilson, Tanya Lehky, et al.Acute Oxaliplatin-Induced Peripheral Nerve Hyperexcitability[J] .J Clin Oncol,2002,20(7):1767 - 1774.
  • 3Adelsberger H,Quasthoff S,Grosskreutz J,et al.The chemotherapeutic oxaliplatin alters voltage-gated Na(+)channel kinetics on rat sensory neurons[J].Eur J Pharmacol,2000,406(1):25-32
  • 4Sarah Taieb, Louis Descos, Gilles Freyer, et al. Lhermitte sign and urinary retention-atypical presentation of oxaliplatin neurotoxicity in four patients[J]. Cancer, 2002,94(9) : 2434 - 2440.
  • 5Misset JL. Oxaliplatin in practice [ J ] . Br J Cancer, 1998, 77(Suppl 4):S4- S7.
  • 6Graham MA, Lockwood GF, Greenslade D, et al. Clinical pharmacokinetics of oxaliplatin; a critical review[ J ] . Clin Cancer Res ,2000,6(4) : 1205 - 1218.
  • 7Levi F, Metzger G, Massari C, et al. Oxaliplatin: pharmacokinetics and chronopharmacological aspeets[J]. Clin Pharmacokinet,2000,38(1) : 1 - 21.
  • 8Luo FR, Wyrick SD, Charley SG. Biotransformations of oxaliplatin in rat blood in vitro[J] .J Biochem Mol Toxicol ,1999 ,13(3-4):159- 169.
  • 9Gamelin E, LeBouil A, Boisdron-celle M, et al. Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluomuracil in colorectal cancer patients[J]. Clin Cancer Res, 1997,3(6) :891 - 899.
  • 10Raymond E, Chaney SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies [ J ]. Ann Oncol, 1998,9 ( 10 ) :1053- 1071.

共引文献129

同被引文献104

引证文献12

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部